BridgeMD
New treatment option for HIV
Official title Proof-of-concept of a Behavioral Intervention to Improve the Cardiovascular Health of People Living With HIV
ClinicalTrials.gov ID: NCT07105007
What this study is testing
- What it's testing
- Heart failure (HF) is a growing health and economic burden around the globe, and it remains a leading cause of morbidity and mortality among the general population. HIV is recognized as an independent risk factor for HF, due to direct and indirect effects.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 40 and older
You may be able to join if
- Confirmed HIV infection (verified on medical record)
- Age ≥40 years
- Classified as heart failure stage A or B (American Heart Association Guidelines)
- On antiretroviral therapy (ART) for ≥12 months
- HIV RNA \<200 copies/mL in the past 12 months
You likely can't join if
- Heart failure stage C or D (AHA Guidelines)
- Participating in structured exercise or weight loss program in the past 6 months
- Exercising ≥3 times per week (≥20 minutes per session)
- Do not report fatigue
- Significant comorbidities (e.g., uncontrolled hypertension, severe musculoskeletal/neurological conditions)
- Pregnant or postmenopausal women
See the full eligibility criteria
- Confirmed HIV infection (verified on medical record)
- Age ≥40 years
- Classified as heart failure stage A or B (American Heart Association Guidelines)
- On antiretroviral therapy (ART) for ≥12 months
- HIV RNA \<200 copies/mL in the past 12 months
- Not engaged in a structured exercise or weight loss program in the past 6 months
- Physically inactive, defined as an activity level of less than 400 METs measured with the Global Physical Activity Questionnaire (GPAQ)
- Independent in basic activities of daily living
- Able to ambulate independently
- Heart failure stage C or D (AHA Guidelines)
- Participating in structured exercise or weight loss program in the past 6 months
- Exercising ≥3 times per week (≥20 minutes per session)
- Do not report fatigue
- Significant comorbidities (e.g., uncontrolled hypertension, severe musculoskeletal/neurological conditions)
- Pregnant or postmenopausal women
The study team makes the final eligibility decision.
Where it's taking place
- Seattle, Washington, United States
- Londrina, Paraná, Brazil
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 40 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Seattle, Washington, United States; Londrina, Paraná, Brazil. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.